Cell Biotech Co. Ltd (049960) — Capital Reinvestment Ratio
Cell Biotech Co. Ltd (049960) has a Capital Reinvestment Ratio of 0.55x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩4.15 Billion) in capital expenditures (₩2.29 Billion). See Cell Biotech Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cell Biotech Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Cell Biotech Co. Ltd's Capital Reinvestment Ratio across 14 annual periods. Check 049960 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cell Biotech Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Cell Biotech Co. Ltd from 2011 to 2024. For live market cap and broader valuation context, see 049960 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩19.27 Billion | ₩1.28 Billion | ▼ -69.2% |
| 2023 | 0.22x | ₩7.82 Billion | ₩1.69 Billion | ▲ +3.4% |
| 2022 | 0.21x | ₩12.81 Billion | ₩2.67 Billion | ▲ +266.0% |
| 2021 | 0.06x | ₩14.89 Billion | ₩848.59 Million | ▼ -82.3% |
| 2020 | 0.32x | ₩9.56 Billion | ₩3.08 Billion | ▼ -65.2% |
| 2019 | 0.93x | ₩10.23 Billion | ₩9.47 Billion | ▲ +81.9% |
| 2018 | 0.51x | ₩13.98 Billion | ₩7.11 Billion | ▲ +114.0% |
| 2017 | 0.24x | ₩22.53 Billion | ₩5.36 Billion | ▲ +98.3% |
| 2016 | 0.12x | ₩17.99 Billion | ₩2.16 Billion | ▼ -35.4% |
| 2015 | 0.19x | ₩18.24 Billion | ₩3.38 Billion | ▲ +32.8% |
| 2014 | 0.14x | ₩9.91 Billion | ₩1.38 Billion | ▼ -80.1% |
| 2013 | 0.70x | ₩8.99 Billion | ₩6.31 Billion | ▲ +29.0% |
| 2012 | 0.54x | ₩6.17 Billion | ₩3.36 Billion | ▲ +411.4% |
| 2011 | 0.11x | ₩5.45 Billion | ₩580.85 Million | — |